CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-08 | Gardiner Nathaniel S. Sr. VP & General Counsel | Exercise or conversion · Stock Option (right to buy) | −4,300 | 78,200 | ||
| 2017-11-17 | Gardiner Nathaniel S. Sr. VP & General Counsel | Grant or award · Stock Option (right to buy) | +21,500 | 21,500 | ||
| 2017-11-17 | Ocain Tim Senior Vice President | Grant or award · Stock Option (right to buy) | +21,500 | 21,500 | ||
| 2017-11-17 | MELLETT PAUL J Treasurer and CFO | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2017-11-17 | Adda Nathalie Sr. VP & Chief Medical Officer | Grant or award · Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2017-11-17 | Or Yat Sun Sr. VP & CSO | Grant or award · Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2017-11-17 | Luly Jay R. President and CEO | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2017-09-11 | Peterson Kristine Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2017-04-12 | Or Yat Sun Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +6,963 | 6,963 | ||
| 2017-04-12 | MELLETT PAUL J Treasurer and CFO | Grant or award · Stock Option (right to buy) | +6,963 | 6,963 | ||
| 2017-04-12 | Luly Jay R. President and CEO | Grant or award · Stock Option (right to buy) | +13,925 | 13,925 | ||
| 2017-04-11 | MELLETT PAUL J Treasurer and CFO | Exercise or conversion | +29,274 | $2.97 | $87K | 91,979 |
| 2017-04-11 | MELLETT PAUL J Treasurer and CFO | Exercise or conversion · Stock Option (right to buy) | −29,274 | 0 | ||
| 2017-02-16 | Russell Lesley Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2017-02-16 | Vance Terry Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2017-02-16 | Golumbeski George Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2017-02-16 | CARTER BRUCE L A Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2017-02-16 | Buckley Stephen Jr. Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2014-01-30 | Ocain Tim Senior Vice President | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 |
Page 31 of 31 · 619 trades